Cutaneous mucormycosis

Detalhes bibliográficos
Autor(a) principal: Castrejón-Pérez,Ana Daniela
Data de Publicação: 2017
Outros Autores: Welsh,Esperanza C., Miranda,Ivett, Ocampo-Candiani,Jorge, Welsh,Oliverio
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Anais brasileiros de dermatologia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962017000300304
Resumo: Abstract Cutaneous mucormycosis is an emerging fungal infection caused by opportunistic fungi of the phylum Glomeromycota. It is frequent in poorly controlled diabetic patients and individuals with immunosuppression. It is usually acquired by direct inoculation through trauma. The clinical presentation is nonspecific, but an indurated plaque that rapidly evolves to necrosis is a common finding. Diagnosis should be confirmed by demonstration of the etiological agent and new molecular diagnostic tools have recently been described. It is an invasive life-threatening disease and in order to improve survival, a prompt diagnosis and multidisciplinary management should be provided. The treatment of choice is amphotericin B, but new azoles, such as posaconazole and isavuconazole, must be considered.
id SBD-1_0b5b5ca4d4974054a03fce8a2dab0fd2
oai_identifier_str oai:scielo:S0365-05962017000300304
network_acronym_str SBD-1
network_name_str Anais brasileiros de dermatologia (Online)
repository_id_str
spelling Cutaneous mucormycosisMucormycosisMucoralesMucorZygomycosisRhizopusAbstract Cutaneous mucormycosis is an emerging fungal infection caused by opportunistic fungi of the phylum Glomeromycota. It is frequent in poorly controlled diabetic patients and individuals with immunosuppression. It is usually acquired by direct inoculation through trauma. The clinical presentation is nonspecific, but an indurated plaque that rapidly evolves to necrosis is a common finding. Diagnosis should be confirmed by demonstration of the etiological agent and new molecular diagnostic tools have recently been described. It is an invasive life-threatening disease and in order to improve survival, a prompt diagnosis and multidisciplinary management should be provided. The treatment of choice is amphotericin B, but new azoles, such as posaconazole and isavuconazole, must be considered.Sociedade Brasileira de Dermatologia2017-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962017000300304Anais Brasileiros de Dermatologia v.92 n.3 2017reponame:Anais brasileiros de dermatologia (Online)instname:Sociedade Brasileira de Dermatologia (SBD)instacron:SBD10.1590/abd1806-4841.20176614info:eu-repo/semantics/openAccessCastrejón-Pérez,Ana DanielaWelsh,Esperanza C.Miranda,IvettOcampo-Candiani,JorgeWelsh,Oliverioeng2017-09-13T00:00:00Zoai:scielo:S0365-05962017000300304Revistahttp://www.anaisdedermatologia.org.br/https://old.scielo.br/oai/scielo-oai.phpabd@sbd.org.br||revista@sbd.org.br1806-48410365-0596opendoar:2017-09-13T00:00Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)false
dc.title.none.fl_str_mv Cutaneous mucormycosis
title Cutaneous mucormycosis
spellingShingle Cutaneous mucormycosis
Castrejón-Pérez,Ana Daniela
Mucormycosis
Mucorales
Mucor
Zygomycosis
Rhizopus
title_short Cutaneous mucormycosis
title_full Cutaneous mucormycosis
title_fullStr Cutaneous mucormycosis
title_full_unstemmed Cutaneous mucormycosis
title_sort Cutaneous mucormycosis
author Castrejón-Pérez,Ana Daniela
author_facet Castrejón-Pérez,Ana Daniela
Welsh,Esperanza C.
Miranda,Ivett
Ocampo-Candiani,Jorge
Welsh,Oliverio
author_role author
author2 Welsh,Esperanza C.
Miranda,Ivett
Ocampo-Candiani,Jorge
Welsh,Oliverio
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Castrejón-Pérez,Ana Daniela
Welsh,Esperanza C.
Miranda,Ivett
Ocampo-Candiani,Jorge
Welsh,Oliverio
dc.subject.por.fl_str_mv Mucormycosis
Mucorales
Mucor
Zygomycosis
Rhizopus
topic Mucormycosis
Mucorales
Mucor
Zygomycosis
Rhizopus
description Abstract Cutaneous mucormycosis is an emerging fungal infection caused by opportunistic fungi of the phylum Glomeromycota. It is frequent in poorly controlled diabetic patients and individuals with immunosuppression. It is usually acquired by direct inoculation through trauma. The clinical presentation is nonspecific, but an indurated plaque that rapidly evolves to necrosis is a common finding. Diagnosis should be confirmed by demonstration of the etiological agent and new molecular diagnostic tools have recently been described. It is an invasive life-threatening disease and in order to improve survival, a prompt diagnosis and multidisciplinary management should be provided. The treatment of choice is amphotericin B, but new azoles, such as posaconazole and isavuconazole, must be considered.
publishDate 2017
dc.date.none.fl_str_mv 2017-06-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962017000300304
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962017000300304
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/abd1806-4841.20176614
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Dermatologia
publisher.none.fl_str_mv Sociedade Brasileira de Dermatologia
dc.source.none.fl_str_mv Anais Brasileiros de Dermatologia v.92 n.3 2017
reponame:Anais brasileiros de dermatologia (Online)
instname:Sociedade Brasileira de Dermatologia (SBD)
instacron:SBD
instname_str Sociedade Brasileira de Dermatologia (SBD)
instacron_str SBD
institution SBD
reponame_str Anais brasileiros de dermatologia (Online)
collection Anais brasileiros de dermatologia (Online)
repository.name.fl_str_mv Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)
repository.mail.fl_str_mv abd@sbd.org.br||revista@sbd.org.br
_version_ 1752126421844623360